Abstract

ObjectiveTo retrospective analyze the clinical data of 162 patients with small cerebellopontine angle meningiomas. To compare with the nature of tumors, symptoms pre- and post-treatments, neurological deficit, and prognosis in literatures. To explore the surgical outcomes of small cerebellopontine angle meningiomas and summarize the surgical experience.MethodsAll of 162 patients with small cerebellopontine angle meningiomas underwent surgery between January 2010 and December 2019 in the neurosurgery department of the First Affiliated Hospital of Soochow University. This cohort of eight literatures reported about stereotactic radiotherapy of small cerebellopontine angle meningiomas between January 2010 and December 2019. All clinical data were obtained for analysis.ResultsCompared with stereotactic radiotherapy, surgical treatment for small cerebellopontine angle meningiomas lead to the better results in relieving symptoms and inhibiting tumor progression. Surgical treatment can obtain the exact pathological examination results to guide the further treatment.ConclusionsSurgical treatment should be the first choice for small cerebellopontine angle meningiomas.

Highlights

  • Cerebellopontine angle meningiomas account for 6–15% of the tumors in the cerebellopontine angle region (1)

  • Surgical treatment is the first choice for large cerebellopontine angle meningiomas, while small cerebellopontine angle meningiomas are always treated by stereotactic radiotherapy, pharmacotherapy and experimental therapy (3)

  • We reviewed the literature on stereotactic radiotherapy of small cerebellopontine angle meningiomas from the past 10 years

Read more

Summary

Objective

To retrospective analyze the clinical data of 162 patients with small cerebellopontine angle meningiomas. To explore the surgical outcomes of small cerebellopontine angle meningiomas and summarize the surgical experience

Methods
Results
INTRODUCTION
Study Design
RESULTS
DISCUSSION
CONCLUSION
ETHICS STATEMENT
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.